These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 25895638

  • 1. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation.
    Romano M, Cianci E, Simiele F, Recchiuti A.
    Eur J Pharmacol; 2015 Aug 05; 760():49-63. PubMed ID: 25895638
    [Abstract] [Full Text] [Related]

  • 2. Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins.
    Serhan CN, Chiang N.
    ScientificWorldJournal; 2002 Jan 22; 2():169-204. PubMed ID: 12806051
    [Abstract] [Full Text] [Related]

  • 3. Lipoxin and aspirin-triggered lipoxins.
    Romano M.
    ScientificWorldJournal; 2010 Jun 02; 10():1048-64. PubMed ID: 20526535
    [Abstract] [Full Text] [Related]

  • 4. Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins.
    Romano M.
    Inflamm Allergy Drug Targets; 2006 Apr 02; 5(2):81-90. PubMed ID: 16613567
    [Abstract] [Full Text] [Related]

  • 5. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN, Chiang N.
    Rheum Dis Clin North Am; 2004 Feb 02; 30(1):69-95. PubMed ID: 15061569
    [Abstract] [Full Text] [Related]

  • 6. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb 02; 73(3-4):141-62. PubMed ID: 16005201
    [Abstract] [Full Text] [Related]

  • 7. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N, Arita M, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Feb 02; 73(3-4):163-77. PubMed ID: 16125378
    [Abstract] [Full Text] [Related]

  • 8. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF.
    Inflamm Allergy Drug Targets; 2006 Apr 02; 5(2):91-106. PubMed ID: 16613568
    [Abstract] [Full Text] [Related]

  • 9. Lipoxin receptors.
    Romano M, Recchia I, Recchiuti A.
    ScientificWorldJournal; 2007 Sep 01; 7():1393-412. PubMed ID: 17767357
    [Abstract] [Full Text] [Related]

  • 10. Lipoxins and aspirin-triggered lipoxins in neutrophil adhesion and signal transduction.
    Filep JG, Khreiss T, József L.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Sep 01; 73(3-4):257-62. PubMed ID: 15979865
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA, Akritopoulou-Zanze I, Fokin VV, Bernasconi G, Keledjian R, Yang R, Uddin J, Nagulapalli KC, Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Sep 01; 73(3-4):301-21. PubMed ID: 16098719
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic regulation of the formyl peptide receptor 2 gene.
    Simiele F, Recchiuti A, Patruno S, Plebani R, Pierdomenico AM, Codagnone M, Romano M.
    Biochim Biophys Acta; 2016 Oct 01; 1859(10):1252-8. PubMed ID: 27424221
    [Abstract] [Full Text] [Related]

  • 13. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution.
    Serhan CN.
    Prostaglandins Other Lipid Mediat; 2002 Aug 01; 68-69():433-55. PubMed ID: 12432935
    [Abstract] [Full Text] [Related]

  • 14. Lipoxins: pro-resolution lipid mediators in intestinal inflammation.
    Goh J, Godson C, Brady HR, Macmathuna P.
    Gastroenterology; 2003 Apr 01; 124(4):1043-54. PubMed ID: 12671901
    [Abstract] [Full Text] [Related]

  • 15. Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side.
    Serhan CN.
    Arch Immunol Ther Exp (Warsz); 2001 Apr 01; 49(3):177-88. PubMed ID: 11478391
    [Abstract] [Full Text] [Related]

  • 16. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.
    Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM.
    Am J Physiol Cell Physiol; 2005 Sep 01; 289(3):C557-63. PubMed ID: 15901601
    [Abstract] [Full Text] [Related]

  • 17. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM, Brady HR.
    Kidney Int Suppl; 1997 Mar 01; 58():S56-61. PubMed ID: 9067945
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.
    Fierro IM, Serhan CN.
    Braz J Med Biol Res; 2001 May 01; 34(5):555-66. PubMed ID: 11323741
    [Abstract] [Full Text] [Related]

  • 19. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion.
    Chiang N, Gronert K, Clish CB, O'Brien JA, Freeman MW, Serhan CN.
    J Clin Invest; 1999 Aug 01; 104(3):309-16. PubMed ID: 10430612
    [Abstract] [Full Text] [Related]

  • 20. Lipoxins and new lipid mediators in the resolution of inflammation.
    Schwab JM, Serhan CN.
    Curr Opin Pharmacol; 2006 Aug 01; 6(4):414-20. PubMed ID: 16750421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.